Pivotal Advance: Glycyrrhizin restores the impaired production of β-defensins in tissues surrounding the burn area and improves the resistance of burn mice to Pseudomonas aeruginosa wound infection

Journal of Leukocyte Biology

Volumn 87, Issue 1, 2010, Pages 35-41

  Yoshida, Tsuyoshi ^a   Yoshida, Shohei ^a   Kobayashi, Makiko ^a,b   Herndon, David N ^b   Suzuki, Fujio ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Antimicrobial peptides; CCL2; IL 10

Indexed keywords

BETA DEFENSIN; CD11B ANTIGEN; GLYCYRRHIZIC ACID; INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BURN INFECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; HOST RESISTANCE; INFECTION RESISTANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; SEPSIS; SUPPRESSOR CELL; SURVIVAL; WOUND INFECTION;

ANIMALS; BETA-DEFENSINS; BURNS; CHEMOKINE CCL2; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GLYCYRRHIZIC ACID; HUMANS; INTERLEUKIN-10; INTERLEUKINS; KERATINOCYTES; MALE; MICE; MICE, INBRED BALB C; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; T-LYMPHOCYTE SUBSETS; WOUND INFECTION;

MUS; PSEUDOMONAS AERUGINOSA;

EID: 74949100484     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1208760     Document Type: Article

References (48)

1. Morrison, V. A. (2001) Infections in the immunocompromised host. In Management of Antimicrobials in Infectious Diseases (A. G. Mainous III, C. Pomeroy, eds.), Totowa, NJ, USA, Humana, 315-330.
2. Hunsicker, L. M., Heggers, J. P., Patel, J. A. (2001) Infections in burn patients. In Clinical Management of Infections in Immunocompromised Infants and Children (C. C. Patrick, ed.), Philadelphia, PA, USA, Lippincott Williams & Wilkins, 327-349.
3. Davey, V. (2002) Immunocompromised persons and emerging infectious diseases. In Emerging Infectious Diseases (F. R. Lashley, J. D. Durham, eds.), New York, NY, USA, Springer, 303-324.
4. Church, D., Elsayed, S., Reid, O., Winston, B., Lindsay, R. (2006) Burn wound infections. Clin. Microbiol. Rev. 19, 403-434.
5. Heggers, J. P., Hawkins, H., Edgar, P., Villarreal, C., Herndon, D. N. (2002) Treatment of infection in burns. In Total Burn Care (D. N. Herndon, ed.), Edinburgh, UK, Saunders, 120-169.
6. Stieritz, D. D., Holder, I. A. (1975) Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. J. Infect. Dis. 131, 688-691.
7. + cells as an accelerator of sepsis stemming from Pseudomonas aeruginosa wound infection in thermally injured mice. J. Leukoc. Biol. 83, 1354-1362.
8. Medzhitov, R., Janeway Jr., C. A. (1997) Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9, 4-9.
9. Akira, S., Uematsu, S., Takeuchi, O. (2006) Pathogen recognition and innate immunity. Cell 124, 783-801.
10. Harder, J., Bartels, J., Christophers, E., Schroeder, J. M. (1997) A peptide antibiotic from human skin. Nature 387, 861-862.
11. Lehrer, R. I., Lichtenstein, A. K., Ganz, T. (1993) Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol. 11, 105-128.
12. Ganz, T., Lehrer, R. I. (2003) Antimicrobial peptide. In Innate Immunity (R. A. B. Ezekowitz, J. A. Hoffmann, eds.), Totowa, NJ, USA, Humana, 287-303.
13. Serafini, P., De Santo, C., Marigo, I., Cingarlini, S., Dolcetti, L., Gallina, G., Zanovello, P., Bronte, V. (2004) Derangement of immune responses by myeloid suppressor cells. Cancer Immunol. Immunother. 53, 64-72.
14. + myeloid suppressor cells cause T cell dysfunction after traumatic stress. J. Immunol. 176, 2085-2094.
15. Sica, A., Bronte, V. (2007) Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117, 1155-1166.
16. Kai, K., Komine, K., Asai, K., Kuroishi, T., Komine, Y., Kozutsumi, T., Itagaki, M., Ohta, M., Endo, Y., Kumagai, K. (2003) Anti-inflammatory effects of intramammary infusions of glycyrrhizin in lactating cows with mastitis caused by coagulase-negative staphylococci. Am. J. Vet. Res. 64, 1213-1220.
17. Genovese, T., Menegazzi, M., Mazzon, E., Crisafulli, C., Di Paola, R., Dal Bosco, M., Zou, Z., Suzuki, H., Cuzzocrea, S. (2009) Glycyrrhizin reduces secondary inflammatory process after spinal cord compression injury in mice. Shock 31, 367-375.
18. Miyaji, C., Miyakawa, R., Watanabe, H., Kawamura, H., Abo, T. (2002) Mechanisms underlying the activation of cytotoxic function mediated by hepatic lymphocytes following the administration of glycyrrhizin. Int. Immunopharmacol. 2, 1079-1086.
19. Zhang, Y. H., Isobe, K., Nagase, F., Lwin, T., Kato, M., Hamaguchi, M., Yokochi, T., Nakashima, I. (1993) Glycyrrhizin as a promoter of the late signal transduction for interleukin-2 production by splenic lymphocytes. Immunology 79, 528-534.
20. Utsunomiya, T., Kobayashi, M., Pollard, R. B., Suzuki, F. (1997) Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus. Antimicrob. Agents Chemother. 41, 551-556.
21. Dai, J. H., Iwatani, Y., Ishida, T., Terunuma, H., Kasai, H., Iwakula, Y., Fujiwara, H., Ito, M. (2001) Glycyrrhizin enhances interleukin-12 production in peritoneal macrophages. Immunology 103, 235-243.
22. Utsunomiya, T., Kobayashi, M., Ito, M., Herndon, D. N., Pollard, R. B., Suzuki, F. (2001) Glycyrrhizin restores the impaired IL-12 production in thermally injured mice. Cytokine 14, 49-55.
23. Utsunomiya, T., Kobayashi, M., Herndon, D. N., Pollard, R. B., Suzuki, F. (1999) Effects of glycyrrhizin, an active component of licorice roots, on Candida albicans infection in thermally injured mice. Clin. Exp. Immunol. 116, 291-298.
24. Utsunomiya, T., Kobayashi, M., Ito, M., Pollard, R. B., Suzuki, F. (2000) Glycyrrhizin improves the resistance of MAIDS mice to opportunistic infection of Candida albicans through the modulation of MAIDS-associated type 2 T cell responses. Clin. Immunol. 95, 145-155.
25. Sasaki, H., Takei, M., Kobayashi, M., Pollard, R. B., Suzuki, F. (2002) Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV sero(+) patients. Pathobiology 70, 229-236.
26. Häkkinen, L., Koivisto, L., Larjava, H. (2001) An improved method for culture of epidermal keratinocytes from newborn mouse skin. Methods Cell Sci. 23, 189-196.
27. Breuss, J. M., Gallo, J., DeLisser, H. M., Klimanskaya, I. V., Folkesson, H. G., Pittet, J. F., Nishimura, S. L., Aldape, K., Landers, D. V., Carpenter, W., Gillett, N., Sheppard1, D., Matthay, M. A., Albelda, S. M., Kramer, R. H., Pytela, R. (1995) Expression of the β 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J. Cell Sci. 108, 2241-2251.
28. Yoshida, T., Tsuda, Y., Takeuchi, D., Kobayashi, M., Pollard, R. B., Suzuki, F. (2006) Glycyrrhizin inhibits neutrophil-associated generation of alternatively activated macrophages. Cytokine 33, 317-322.
29. Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., Leung, D. Y. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347, 1151-1160.
30. Morrison, G., Kilanowski, F., Davidson, D., Dorin, J. (2002) Characterization of the mouse β defensin 1, Defb1, mutant mouse model. Infect. Immun. 70, 3053-3060.
31. Moser, C., Weiner, D. J., Lysenko, E., Bals, R., Weiser, J. N., Wilson, J. M. (2002) β-Defensin 1 contributes to pulmonary innate immunity in mice. Infect. Immun. 70, 3068-3072.
32. Steinstraesser, L., Oezdogan, Y., Wang, S. C., Steinau, H. U. (2004) Host defense peptides in burns. Burns 30, 619-627.
33. Sawamura, D., Goto, M., Shibaki, A., Akiyama, M., McMillan, J. R., Abiko, Y., Shimizu, H. (2005) β Defensin-3 engineered epidermis shows highly protective effect for bacterial infection. Gene Ther. 12, 857-861.
34. Braff, M. H., Gallo, R. L. (2006) Antimicrobial peptides: an essential component of the skin defensive barrier. Curr. Top. Microbiol. Immunol. 306, 91-110.
35. Hirsch, T., Metzig, M., Niederbichler, A., Steinau, H. U., Eriksson, E., Steinstraesser, L. (2008) Role of host defense peptides of the innate immune response in sepsis. Shock 30, 117-126.
36. Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., Gallo, R. L. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454-457.
37. Chromek, M., Slamová, Z., Bergman, P., Kovács, L., Podracká, L., Ehrén, I., Hökfelt, T., Gudmundsson, G. H., Gallo, R. L., Agerberth, B., Brauner, A. (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12, 636-641.
38. Jacobsen, F., Mittler, D., Hirsch, T., Gerhards, A., Lehnhardt, M., Voss, B., Steinau, H. U., Steinstraesser, L. (2005) Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections. Gene Ther. 12, 1494-1502.
39. Milner, S. M., Ortega, M. R. (1999) Reduced antimicrobial peptide expression in human burn wounds. Burns 25, 411-413.
40. Ortega, M. R., Ganz, T., Milner, S. M. (2000) Human β defensin is absent in burn blister fluid. Burns 26, 724-726.
41. Kaus, A., Jacobsen, F., Sorkin, M., Rittig, A., Voss, B., Daigeler, A., Sudhoff, H., Steinau, H. U., Steinstraesser, L. (2008) Host defence peptides in human burns. Burns 34, 32-40.
42. Tsuda, Y., Takahashi, H., Kobayashi, M., Hanafusa, T., Herndon, D. N., Suzuki, F. (2004) Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 21, 215-226.
43. Sato, H., Goto, W., Yamamura, J., Kurokawa, M., Kageyama, S., Takahara, T., Watanabe, A., Shiraki, K. (1996) Therapeutic basis of glycyrrhizin on chronic hepatitis B. Antiviral Res. 30, 171-177.
44. Patrick, L. (1999) Hepatitis C: epidemiology and review of complementary/ alternative medicine treatments. Altern. Med. Rev. 4, 220-238.
45. Orlent, H., Hansen, B. E., Willems, M., Brouwer, J. T., Huber, R., Kullak-Ublick, G. A., Gerken, G., Zeuzem, S., Nevens, F., Tielemans, W. C., Zondervan, P. E., Lagging, M., Westin, J., Schalm, S. W. (2006) Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial. J. Hepatol. 45, 539-546.
46. + myeloid suppressor cells cause T cell dysfunction after traumatic stress. J. Immunol. 176, 2085-2094.
47. Noel, J. G., Guo, X., Wells-Byrum, D., Schwemberger, S., Caldwell, C. C., Ogle, C. K. (2005) Effect of thermal injury on splenic myelopoiesis. Shock 23, 115-122.
48. + population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204, 1463-1474.